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• Objectives: 
 
– To assess the situation in Europe regarding the problem of 
alcohol and/or other psychoactive substances in relation to road 
safety  
• Prevalence in  
the driving population 
• Prevalence in seriously 
injured drivers 
• Prevalence in 
killed drivers 
• Risk of injury for  
drink and/or drug drivers 
DRUID PROJECT - Epidemiology 
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Prevalence in the driving population 
• Alcohol and other psychoactive substances in 
drivers in the general traffic (Report D 2.2.3) 
 
Aim of the roadside surveys: 
To estimate the prevalence of 
psychoactive substances, including 
alcohol in the general driving 
population  
 
Method:  
Roadside surveys in 13 countries by 
means of a uniform protocol in all 
countries 
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Prevalence in the driving population 
• Alcohol and other psychoactive substances 
in drivers in the general traffic 
 
Data collection:  
Blood and/or saliva collected 
Information on age, gender, place, 
time of the sampling …. 
In total app. 50,000 drivers of 
passenger cars and vans 
Participating countries 
BE, CZ, DK, ES, FI, HU, IT, LT, NL, 
NO, PL, PT and SE 
Samples weighted by traffic in 8 
periods of the week 
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The following drugs were analysed for: 
Alcohol 
Amphetamines 
Cocaine 
Cannabis 
Illicit opiates 
- mainly morphine 
Benzodiazepines 
Medicinal opioids 
Illicit drugs Medicinal drugs 
Psychoactive substances 
Z-drugs 
Positive concentrations were based on the same cut-offs in all studies 
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Equivalent cut-offs  
Substance Recommended  equivalent 
cut-off in whole blood  (ng/mL) 
Recommended equivalent 
cut-off in oral fluid (ng/mL) 
Ethanol 0.1 (g/L) 0.082 (g/L) 
6-AM 10 161 
Alprazolam 10 3.5 
Amphetamine 20 360 
Benzoylecgonine 50 95 
Clonazepam 10 1.7 
Cocaine 10 170 
Codeine 10 94 
Diazepam 140 5.02 
Flunitrazepam 5.31 1.02 
Lorazepam 10 1.1 
MDA 20 2201 
MDEA 20 2703 
MDMA 20 2701 
Methadone 10 22 
Methamphetamine 20 410 
Morphine 10 95 
Nordiazepam 20 1.1 
Oxazepam 50 13 
THC 1.0 27 
Zolpidem 37 102 
Zopiclone 10 251 
Tramadol 50 480 
7-amino-clonazepam 1.0 3.11 
7-amino-flunitrazepam 8.51 1.02 
 
Body fluid 
collected: 
 
1. Saliva 
2. Blood 
3. Both 
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Prevalence in the driving population 
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Alcohol is still the most prevalent substance in the driving population 
-  but most of the drink driving was with concentrations below 0.5 g/L 
Prevalence of alcohol 
Alcohol  
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Prevalence of alcohol in 
combination with other drugs 
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Prevalence in the driving population 
Illicit drugs are most prevalent in southern and western Europe 
Driving with medicinal drugs was observed all over Europe 
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Prevalence of illicit drugs 
Prevalence of medicinal drugs 
Illicit and medicinal drugs 
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Prevalence in accident involved drivers 
• Alcohol and other psychoactive substances in 
seriously injured and killed drivers (Report D 2.2.5) 
 
Aim of the studies on injured drivers: 
To estimate the prevalence of 
psychoactive substances, including 
alcohol in seriously injured drivers and 
in killed drivers from traffic accidents 
 
Method:  
Studies of patients from traffic 
accidents in 6 countries and studies of 
killed drivers in 4 countries by means of 
a uniform protocol in all countries 
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Prevalence in accident involved drivers 
• Alcohol and other drugs in seriously injured 
and killed drivers 
 
Data collection:  
Blood was collected 
Information on age, gender, time of 
accident and blood sampling, place, 
injury severity, medical treatment. 
In total 
- App. 2,600 seriously injured drivers 
- App. 1,000 killed drivers of passenger  
  cars and vans 
Participating countries 
- Seriously injured drivers from 
  BE, DK, FI, IT, LT and NL 
- Killed drivers from 
  FI, NO, PT and SE 
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Prevalence in accident involved drivers 
Alcohol  
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Among the alcohol positive drivers – both seriously injured and killed, the majority had 
a blood alcohol concentration equal to or above 0,5 g/L 
Combined use of alcohol and other drugs is considerable in a number of countries 
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Prevalence in accident involved drivers 
Illicit and medicinal drugs  
   
For most illicit and medicinal drugs, the percentage of combined drug use exceeded 
that of single drug use 
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Risk studies 
• Risk of injury by driving with alcohol and 
other drugs (Report D 2.3.5) 
Method:   
Case-control study based on  
 - Data from seriously injured/killed drivers (cases) 
 - Data from road side surveys (controls) 
Assessment of the risk for drivers of passenger cars 
and vans 
 - Alcohol 
 - Illicit and medicinal drugs 
 - Alcohol combined with drugs 
 - Multiple drug use 
I.  Risk of serious injury  
  - BE, DK, FI, IT, LT and NL 
II. Risk of fatality 
   - FI, NO, PT and SE 
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Case-control design 
Cases I 
Drivers of passenger cars/vans 
Seriously injured (MAIS≥2) 
Blood samples, N=2,490 
Cases II 
Drivers of passenger cars/vans 
Killed in traffic 
Blood samples, N=1,112 
Controls 
Drivers of passenger cars/vans 
Stratified sample 
Checked at random 
Blood and saliva samples,  
N= 15,832 (I)  
N=21,917 (II) 
Risk studies 
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Case-control design 
Risk studies 
 
Cases  
(acc=1) 
 
Controls  
(acc=0) 
 
Sum 
 
Exposed (subst=1) 
 
a 
 
b 
 
a+b 
 
Non-exposed (subst=0) 
 
c 
 
d 
 
c+d 
The odds ratio is a ratio between two odds  
1. The odds of having the event among subjects who were positive for a given 
    substance group (subst=1)  -  a/b 
2. The odds of having the event among non-exposed subjects (subst=0)  -  c/d 
 
Results are based on logistic regression and adjusted for age, gender and country  
 
 
The event for a driver is 
• Getting injured in a road accident (acc=1) while positive (subst=1)  
• Getting injured in a road accident (acc=1) while negative (subst=0).  
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Drivers’ risk of getting seriously injured 
Odds ratios based on data from six countries 
(DK, FI, LT, IT, BE, NL) 
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Drivers’ risk of getting killed 
Odds ratios based on data from four countries 
(FI, NO, SE, PT) 
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Detailed risk results based on all countries 
Medium increased risk 
Overall risk levels 
Hatching  - results must be handled with care 
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Risk studies 
Risk level Risk Substance group
Slightly increased risk 1-3 0.1 g/L ≤ alcohol in blood < 0.5 g/L
Cannabis
Medium increased risk 2-10 0.5 g/L ≤ alcohol in blood < 0.8 g/L
Benzoylecgonine
Cocaine
Illicit opiates
Benzodiazepines and Z-drugs
Medicinal opioids
Highly increased risk 5-30 0.8 g/L ≤ alcohol in blood < 1.2 g/L
Amphetamines
Multiple drugs
Extremely increased risk 20-200 Alcohol in blood ≥ 1.2 g/L
Alcohol in combination with drugs
In conclusion -  
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